Comparative analysis of prescribing patterns of tetracycline class antibiotics and spironolactone between advanced practice providers and physicians in the treatment of acne vulgaris - 10/03/21
Funding sources: Dr Barbieri is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number T32-AR-007465 and receives partial salary support through a Pfizer Fellowship grant to the Trustees of the University of Pennsylvania. |
|
Conflicts of interest: Dr Guzman discloses the receipt of travel reimbursement from Verrica Pharmaceuticals, consulting fees from Cello Health, and advisory board participation with Janssen. |
|
IRB approval status: Institutional Review Board approval was not required because all research activities were performed using publicly available deidentified information. |
|
Reprints not available from the authors. |
Vol 84 - N° 4
P. 1119-1121 - avril 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?